Mankind Pharma Ltd. (MANKIND): Mankind Pharma Share Price Rises 2.07% as Stock Climbs to Rs 2,490.05

Published: 29 September 2026 at 10:23:11 AM IST

Mankind Pharma Share Price was in focus today after the stock rose 2.07% to Rs 2,490.05 from Rs 2,439.55. The company’s market capitalisation stood at Rs 1,02,247.25 crore, placing the move in a large listed healthcare name by market value, while turnover was Rs 4.78 crore. The day’s open, low and previous close were all Rs 2,439.55, and the stock touched an intraday high of Rs 2,500.00. The data confirms a same-day price rise, but it does not establish a company-specific catalyst. In this Mankind Pharma Share Price update, investors can track whether the move is sustained in subsequent sessions, alongside valuation, earnings and sector comparison on Univest.

The latest Mankind Pharma Stock News is therefore best read as a verified price event rather than a catalyst-led development. The stock’s rise added Rs 50.50 to the previous close and moved the share close to the day’s high. For readers searching Mankind Pharma Share Price Today, the important facts are the current price, the percentage move, the market cap and the fact that no separate explanation is provided by the supplied data. Univest is following the stock through price action, fundamentals and industry context so the day’s move can be read in a broader research frame.

Mankind Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,490.05
Previous Close	Rs 2,439.55
Today's Move	Rs 50.5 (+2.07%)
Open	Rs 2,439.55
High	Rs 2,500
Low	Rs 2,439.55
Turnover	Rs 4.78 crore
Market Capitalisation	Rs 1,02,247.25 crore
Market Cap Category	Large Cap

Mankind Pharma Ltd. (MANKIND) rose to Rs 2,490.05 from the previous close of Rs 2,439.55, a move of Rs 50.5 or 2.07%. The stock opened at Rs 2,439.55, reached a high of Rs 2,500, recorded a low of Rs 2,439.55.

Mankind Pharma Share Price Today shows a clean upward session with the stock opening at Rs 2,439.55, matching the previous close, and moving to a high of Rs 2,500.00 before ending at Rs 2,490.05. The stock traded above its opening level through the session and finished Rs 50.50 higher, which equals a 2.07% gain. That makes Mankind Pharma one of the names appearing in Stocks in News and among stocks rising today on a purely factual basis. The price action confirms a positive day for Mankind Pharma Share Price, while the supplied data does not establish why the move happened. For anyone tracking Mankind Pharma Stock News, the key takeaway is the upward close near the day’s high and the unchanged relationship between open and previous close.

In Share Market Today terms, the move is straightforward: the stock remained in a narrow range between Rs 2,439.55 and Rs 2,500.00, and the closing price held most of the intraday advance. Univest classifies this as a verified price rise, not as an event with a disclosed trigger. That distinction matters for Mankind Pharma Share Price Live readers who want factual market updates without speculation. The move also keeps Mankind Pharma Share Price in the conversation for those scanning market movers in the Indian stock market, even though the data supplied here does not point to a stated catalyst.

Mankind Pharma Ltd. (MANKIND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,02,247.25 crore
P/E Ratio	49.33x
P/B Ratio	5.99x
ROE	12.69%
ROCE	13.24%
EPS	Rs 49.45
Book Value Per Share	Rs 407.39
Dividend Yield	0.04%

Mankind Pharma Ltd. (MANKIND) fundamental metrics show P/E 49.33x, P/B 5.99x, ROE 12.69%, ROCE 13.24%. These figures provide context only and are not a buy or sell signal.

Mankind Pharma Ltd. has a market capitalisation of Rs 102247.25 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.33x, P/B at 5.99x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 49.45, book value per share of Rs 407.39, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	49.33x
Benchmark Median P/E	32.59x
Benchmark Average P/E	49x
Benchmark P/E Range	3.46x to 707.31x
Company P/B Ratio	5.99x
Benchmark Median P/B	2.88x
Company ROE	12.69%
Benchmark Median ROE	11.7%
Company ROCE	13.24%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 1,02,247.25 crore
Benchmark Median Market Cap	Rs 783.26 crore

Mankind Pharma Ltd. (MANKIND) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 49.33x, which is above the benchmark median of 32.59x, a difference of +51.37%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Mankind Pharma Ltd. (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 11.7%, a difference of +8.46%. Mankind Pharma Ltd. (MANKIND) has a ROCE of 13.24%, which is below the benchmark median of 13.61%, a difference of -2.72%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,44,716.74	36.5	5.1	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,55,115.31	86.51	14.33	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,613.38	84.92	20.64	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,19,899.96	26.79	4.48	19.69	21.39
Cipla Ltd.	CIPLA	1,12,875.68	33.29	3.19	11.83	16

Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 49.33x compared with the displayed peer median of 36.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Mankind Pharma Ltd. (MANKIND) has a market capitalisation of Rs 1,02,247.25 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Mankind Pharma

• Mankind Pharma Share Price rose 2.07% today to Rs 2,490.05, with the session high at Rs 2,500.00.
• The company’s market capitalisation stood at Rs 1,02,247.25 crore, keeping the move relevant in healthcare market updates.
• P/E was 49.33, close to the same-industry average of 49.00 and above the industry median of 32.59.
• EPS was Rs 49.45 and book value was Rs 407.39 per share, which gives Mankind Pharma Fundamental Analysis added context.
• In the peer set, Mankind Pharma’s ROE of 12.69% was below several listed healthcare names, while ROCE of 13.24% also trailed the supplied peers.

About Mankind Pharma

Mankind Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company through its listed market profile and valuation set, which is enough to place it within India’s organised pharmaceutical universe. In business terms, the company’s share price is tracked alongside earnings, book value, return ratios and peer benchmarks because these are the core financial signals supplied here.

For readers of Mankind Pharma Share Price and Mankind Pharma Company News, the company sits in a sector where both scale and valuation matter. The market cap of Rs 1,02,247.25 crore shows a large listed business in the industry sample, while the ratios provided in this article help explain how the market is valuing the stock relative to similar pharmaceutical names. Univest uses this company context to make Mankind Pharma Stock Analysis easier to follow without adding unsupported claims.

Track Mankind Pharma Share Price on Univest

Use Mankind Pharma Ltd. (MANKIND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Mankind Pharma Share Price on Univest for live price updates, valuation ratios, fundamental analysis, shareholding pattern, 52-week levels and broader market insights. The stock page also helps connect Mankind Pharma Share Price Today with sector context, peer comparison and company financials in one place.

Frequently Asked Questions

Why did Mankind Pharma Share Price rise today?

Ans. Mankind Pharma Share Price rose 2.07% to Rs 2,490.05, but the supplied data does not establish a company-specific catalyst. The session closed near the day’s high of Rs 2,500.00. The previous close was Rs 2,439.55.

What was the current price of Mankind Pharma Share Price today?

Ans. Mankind Pharma Share Price closed at Rs 2,490.05 today, after opening at Rs 2,439.55 and moving as high as Rs 2,500.00 during the session. The previous close was also Rs 2,439.55.

How much did Mankind Pharma Share Price gain today?

Ans. Mankind Pharma Share Price gained Rs 50.50 on the day, which equals a 2.07% rise. That move took the stock from Rs 2,439.55 to Rs 2,490.05 by the close. The previous close was Rs 2,439.55.

What is the market cap of Mankind Pharma Share Price?

Ans. Mankind Pharma’s market capitalisation stood at Rs 1,02,247.25 crore. That places the stock well above the median company size in the same-industry benchmark set supplied for this article. The previous close was Rs 2,439.55.

How is Mankind Pharma Share Price valued versus the industry?

Ans. Mankind Pharma Share Price carried a P/E of 49.33 and a P/B of 5.99. Both are above the same-industry medians, while ROE of 12.69% is slightly above the industry median.

How does Mankind Pharma compare with healthcare peers?

Ans. Mankind Pharma’s P/E of 49.33 sits above Cipla and Sun Pharma, below Divi's Laboratories and Torrent, and above Zydus Lifesciences. Its ROCE of 13.24% is below all four supplied peers.

What do EPS and book value show for Mankind Pharma Share Price?

Ans. EPS was Rs 49.45 and book value was Rs 407.39 per share. EPS shows earnings attributable to each share, while book value reflects the accounting net worth behind each share.

What should investors monitor next for Mankind Pharma Share Price?

Ans. Investors can monitor how Mankind Pharma Share Price behaves in the next sessions, plus valuation, earnings and industry comparison. Univest will keep the stock updated with live price, ratios and sector context.